PKU is an autosomal recessive genetic disorder caused by a deficiency in the enzyme phenylalanine hydroxylase. This enzyme is necessary to break down the amino acid phenylalanine. Without it, phenylalanine builds up to toxic levels in the blood and brain, which can lead to intellectual disabilities if left untreated. PKU is typically detected via newborn screening and treated through a lifelong low-phenylalanine diet. Some cases may also be managed through medication. Strict dietary control is necessary before and during pregnancy for women with PKU to prevent complications in their babies.
This presentation is about the a disease , causes and cure.
Also it contains the experiments done on mouse models.I tried to explain it with the help of cathy diagrams.
Phenylketonuria is one of fthe inborn error of metabolism. Its characteristically error in amino acid metabolism. This causes aminoaciduria. Phenylalanine is an amino acid requied for protein synthesis as well as synthesis of tyrosine. Deficiency of the enzyme phenylalanine hyydroxylase triggers the accumulation of phenylalanine in the blood and subsequent conversion and transamination to ohenylpyruvate which is a phenylketone. This causes accumulation of phenylketones in urine with characteristicc mousy smell.
This slide discussess the causes and biochemistry of this error.
This presentation is about the a disease , causes and cure.
Also it contains the experiments done on mouse models.I tried to explain it with the help of cathy diagrams.
Phenylketonuria is one of fthe inborn error of metabolism. Its characteristically error in amino acid metabolism. This causes aminoaciduria. Phenylalanine is an amino acid requied for protein synthesis as well as synthesis of tyrosine. Deficiency of the enzyme phenylalanine hyydroxylase triggers the accumulation of phenylalanine in the blood and subsequent conversion and transamination to ohenylpyruvate which is a phenylketone. This causes accumulation of phenylketones in urine with characteristicc mousy smell.
This slide discussess the causes and biochemistry of this error.
This fill is represented has the WHAT IS PHENYLKETONURIA,DISCOVERY,NORMAL LEVEL IN BLOOD, HEREDITY,DEFECTS OF CHROMOSOME,CLASSESS OF PHENYLKETONURIA, SYMPTOMS, DIAGNOSIS, TREATMENT &etc...
The slides gives you a complete information on the inborn error metabolic disease Phenylketonuria (PKU) its cause, symptoms, mechanism and dietary management.
Phenylketonuria (commonly known as PKU) is an inherited disorder that increases the levels of a substance called phenylalanine in the blood. Phenylalanine is a building block of proteins (an amino acid) that is obtained through the diet. It is found in all proteins and in some artificial sweeteners. If PKU is not treated, phenylalanine can build up to harmful levels in the body, causing intellectual disability and other serious health problems.
INBORN ERRORS OF METABOLISM, PKU, PHENYLKETONURIA, BY: MR. DINABANDHU BARAD, MSC TUTOR, SUM NURSING COLLEGE, SIKSHA O ANUSANDHAN DEEMED TO BE UNIVERSITY, BHUBANESWAR, ODISHA
Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. A birth defect that causes an amino acid called phenylalanine to build up in the body.
Newborns should be screened for PKU.
Untreated phenylketonuria can lead to brain damage, intellectual disabilities, behavioural symptoms or seizures.
Treatment includes a strict diet with limited protein.
Phenylketonuria (commonly known as PKU) is an inherited disorder that increases the levels of a substance called phenylalanine in the blood. Phenylalanine is a building block of proteins (an amino acid) that is obtained through the diet. It is found in all proteins and in some artificial sweeteners.
This fill is represented has the WHAT IS PHENYLKETONURIA,DISCOVERY,NORMAL LEVEL IN BLOOD, HEREDITY,DEFECTS OF CHROMOSOME,CLASSESS OF PHENYLKETONURIA, SYMPTOMS, DIAGNOSIS, TREATMENT &etc...
The slides gives you a complete information on the inborn error metabolic disease Phenylketonuria (PKU) its cause, symptoms, mechanism and dietary management.
Phenylketonuria (commonly known as PKU) is an inherited disorder that increases the levels of a substance called phenylalanine in the blood. Phenylalanine is a building block of proteins (an amino acid) that is obtained through the diet. It is found in all proteins and in some artificial sweeteners. If PKU is not treated, phenylalanine can build up to harmful levels in the body, causing intellectual disability and other serious health problems.
INBORN ERRORS OF METABOLISM, PKU, PHENYLKETONURIA, BY: MR. DINABANDHU BARAD, MSC TUTOR, SUM NURSING COLLEGE, SIKSHA O ANUSANDHAN DEEMED TO BE UNIVERSITY, BHUBANESWAR, ODISHA
Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. A birth defect that causes an amino acid called phenylalanine to build up in the body.
Newborns should be screened for PKU.
Untreated phenylketonuria can lead to brain damage, intellectual disabilities, behavioural symptoms or seizures.
Treatment includes a strict diet with limited protein.
Phenylketonuria (commonly known as PKU) is an inherited disorder that increases the levels of a substance called phenylalanine in the blood. Phenylalanine is a building block of proteins (an amino acid) that is obtained through the diet. It is found in all proteins and in some artificial sweeteners.
Background Phenylketonuria is an inherited disease which re.pdfaisprayers
Background: Phenylketonuria is an inherited disease which results from the lack of the enzyme
phenylalanine hydroxylase (PAH). The PAH enzyme catalyzes the first step in the degradation of
phenylalanine, as shown in Figure 30.1. In the phenylketonuric patient, phenylalanine accumulates
which is eventually transaminated to phenylpyruvate, a phenylketone compound. Excess
phenylpyruvate accumulates in the blood and urine and has the effect of causing mental
retardation if untreated. Screening programs identify PKU babies at birth, and treatment consists
of a low phenylalanine diet until maturation of the brain is completed. The structure and
biochemical properties of the PAH enzyme have been well-studied.The gene for PAH has been
isolated and has been localized to chromosome 12. The PAH enzyme is a protein 451 amino
acids in length with a molecular weight of 51,900 daltons. More than 60 different mutant genes
giving rise to nonfunctional PAH proteins have been identified in PKU patients.
Question:Kinetic data in which PAH activity is compared with and without preincubation with
phenylalanine is shown in Figure 30.3. Give a structural basis for the interpretation of these data.
Figure 30.1. Phenylalanine and tyrosine meravurior. an essential cofactor for phenylalanine
hydroxylase. 95Figure 30.1. Phenylalanine and tyrosmio ..... an essential cofactor for
phenylalanine hydroxylase. 95.
Background Phenylketonuria is an inherited disease which re.pdfsaravanfncy
Background: Phenylketonuria is an inherited disease which results from the lack of the enzyme
phenylalanine hydroxylase (PAH). The PAH enzyme catalyzes the first step in the degradation of
phenylalanine, as shown in Figure 30.1. In the phenylketonuric patient, phenylalanine accumulates
which is eventually transaminated to phenylpyruvate, a phenylketone compound. Excess
phenylpyruvate accumulates in the blood and urine and has the effect of causing mental
retardation if untreated. Screening programs identify PKU babies at birth, and treatment consists
of a low phenylalanine diet until maturation of the brain is completed. The structure and
biochemical properties of the PAH enzyme have been well-studied.The gene for PAH has been
isolated and has been localized to chromosome 12. The PAH enzyme is a protein 451 amino
acids in length with a molecular weight of 51,900 daltons. More than 60 different mutant genes
giving rise to nonfunctional PAH proteins have been identified in PKU patients.
Question:Kinetic data in which PAH activity is compared with and without preincubation with
phenylalanine is shown in Figure 30.3. Give a structural basis for the interpretation of these data.
Figure 30.1. Phenylalanine and tyrosine meravurior. an essential cofactor for phenylalanine
hydroxylase. 95Figure 30.1. Phenylalanine and tyrosmio ..... an essential cofactor for
phenylalanine hydroxylase. 95.
Barbara K. Burton, MD, and Nicola Longo, MD, PhD, prepared useful practice aids pertaining to phenylketonuria for this CME activity titled "The Evolving Role of Current and Novel Therapies in Improving Outcomes in Adults With PKU." For the full presentation, monograph, complete CME information, and to apply for credit, please visit us at http://bit.ly/2sBC77b. CME credit will be available until June 13, 2019.
Drug therapy in pregnancy and lactationVishnupriya K
This slide share will provide drugs which are used and which are contraindicated during pregnancy and lactation, also give information about side effects and malformations if pregnant women's used some drugs.
Honest Reviews of Tim Han LMA Course Program.pptxtimhan337
Personal development courses are widely available today, with each one promising life-changing outcomes. Tim Han’s Life Mastery Achievers (LMA) Course has drawn a lot of interest. In addition to offering my frank assessment of Success Insider’s LMA Course, this piece examines the course’s effects via a variety of Tim Han LMA course reviews and Success Insider comments.
2024.06.01 Introducing a competency framework for languag learning materials ...Sandy Millin
http://sandymillin.wordpress.com/iateflwebinar2024
Published classroom materials form the basis of syllabuses, drive teacher professional development, and have a potentially huge influence on learners, teachers and education systems. All teachers also create their own materials, whether a few sentences on a blackboard, a highly-structured fully-realised online course, or anything in between. Despite this, the knowledge and skills needed to create effective language learning materials are rarely part of teacher training, and are mostly learnt by trial and error.
Knowledge and skills frameworks, generally called competency frameworks, for ELT teachers, trainers and managers have existed for a few years now. However, until I created one for my MA dissertation, there wasn’t one drawing together what we need to know and do to be able to effectively produce language learning materials.
This webinar will introduce you to my framework, highlighting the key competencies I identified from my research. It will also show how anybody involved in language teaching (any language, not just English!), teacher training, managing schools or developing language learning materials can benefit from using the framework.
Unit 8 - Information and Communication Technology (Paper I).pdfThiyagu K
This slides describes the basic concepts of ICT, basics of Email, Emerging Technology and Digital Initiatives in Education. This presentations aligns with the UGC Paper I syllabus.
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...Levi Shapiro
Letter from the Congress of the United States regarding Anti-Semitism sent June 3rd to MIT President Sally Kornbluth, MIT Corp Chair, Mark Gorenberg
Dear Dr. Kornbluth and Mr. Gorenberg,
The US House of Representatives is deeply concerned by ongoing and pervasive acts of antisemitic
harassment and intimidation at the Massachusetts Institute of Technology (MIT). Failing to act decisively to ensure a safe learning environment for all students would be a grave dereliction of your responsibilities as President of MIT and Chair of the MIT Corporation.
This Congress will not stand idly by and allow an environment hostile to Jewish students to persist. The House believes that your institution is in violation of Title VI of the Civil Rights Act, and the inability or
unwillingness to rectify this violation through action requires accountability.
Postsecondary education is a unique opportunity for students to learn and have their ideas and beliefs challenged. However, universities receiving hundreds of millions of federal funds annually have denied
students that opportunity and have been hijacked to become venues for the promotion of terrorism, antisemitic harassment and intimidation, unlawful encampments, and in some cases, assaults and riots.
The House of Representatives will not countenance the use of federal funds to indoctrinate students into hateful, antisemitic, anti-American supporters of terrorism. Investigations into campus antisemitism by the Committee on Education and the Workforce and the Committee on Ways and Means have been expanded into a Congress-wide probe across all relevant jurisdictions to address this national crisis. The undersigned Committees will conduct oversight into the use of federal funds at MIT and its learning environment under authorities granted to each Committee.
• The Committee on Education and the Workforce has been investigating your institution since December 7, 2023. The Committee has broad jurisdiction over postsecondary education, including its compliance with Title VI of the Civil Rights Act, campus safety concerns over disruptions to the learning environment, and the awarding of federal student aid under the Higher Education Act.
• The Committee on Oversight and Accountability is investigating the sources of funding and other support flowing to groups espousing pro-Hamas propaganda and engaged in antisemitic harassment and intimidation of students. The Committee on Oversight and Accountability is the principal oversight committee of the US House of Representatives and has broad authority to investigate “any matter” at “any time” under House Rule X.
• The Committee on Ways and Means has been investigating several universities since November 15, 2023, when the Committee held a hearing entitled From Ivory Towers to Dark Corners: Investigating the Nexus Between Antisemitism, Tax-Exempt Universities, and Terror Financing. The Committee followed the hearing with letters to those institutions on January 10, 202
The French Revolution, which began in 1789, was a period of radical social and political upheaval in France. It marked the decline of absolute monarchies, the rise of secular and democratic republics, and the eventual rise of Napoleon Bonaparte. This revolutionary period is crucial in understanding the transition from feudalism to modernity in Europe.
For more information, visit-www.vavaclasses.com
Read| The latest issue of The Challenger is here! We are thrilled to announce that our school paper has qualified for the NATIONAL SCHOOLS PRESS CONFERENCE (NSPC) 2024. Thank you for your unwavering support and trust. Dive into the stories that made us stand out!
2. Phenylketonuria (PKU) is an autosomal recessive metabolic genetic disorder
When the mutation takes place at the gene responsible for the hepatic enzyme
phenylalanine hydroxylase (PAH), rendering it nonfunctional
This enzyme is necessary to metabolize the amino acid phenylalanine (Phe) to the
amino acid tyrosine
When PAH activity is reduced, phenylalanine accumulates and is converted
into phenylpyruvate (also known as phenylketone), which can be detected in the urine
Introduction
3.
4. Phenylketonuria was discovered by the Norwegian physician Ivar Asbjørn
Følling in 1934
he noticed hyperphenylalaninemia (HPA) was associated with mental
retardation. In Norway, this disorder is known as Følling's disease
It was recently suggested that PKU may resemble amyloid diseases, such
as Alzheimer's disease and Parkinson's disease, due to the formation of
toxic amyloid-like assemblies of phenylalanin
History
5. Screening and presentation
PKU is commonly included in the newborn screening panel.
Most babies in developed countries are screened for PKU soon after birth
Screening for PKU is done with bacterial inhibition assay (Guthrie test)
immunoassays using fluorometric or photometric detection, or amino acid
measurement using tandem mass spectrometry(MS/MS).
Measurements done using MS/MS determine the concentration of Phe
and the ratio of Phe to tyrosine, both of which will be elevated in PKU
6. If a child is not screened during the routine newborn screening test.
the disease may present clinically with seizures, albinism , and a "musty odor"
to the baby's sweat and urine
Untreated children are normal at birth, but fail to attain early developmental
milestones, develop microcephaly, Hyperactivity, EEG abnormalities, and
seizures, and severe learning disabilities are major clinical problems .
7. Classical PKU is caused by a mutated gene for the
enzyme phenylalanine hydroxylase (PAH), which
converts the amino acid phenylalanine to other
essential compounds in the body
Non-PAH mutations can also cause PKU.
This is an example of non-allelic genetic
heterogeneity
The PAH gene is located on chromosome 12 in the
bands 12q22-q24.1.
More than 400 disease-causing mutations have
been found in the PAH gene.
PAH deficiency causes a spectrum of disorders,
including classic phenylketonuria (PKU) and
hyperphenylalaninemia
Pathophysiology
8. PKU is known to be an autosomal recessive genetic disorder.
This means both parents must have at least one
mutated allele of the PAH gene.
The child must inherit both mutated alleles, one from each
parent.
Therefore, it is possible for a parent with the disease to have a
child without it if the other parent possesses one functional
allele of the gene for PAH.
Yet, a child from two parents with PKU will inherit two
mutated alleles every time, and therefore the disease
9.
10. Hyperphenylalaninemia occurs when PAH is normal
There is a defect in the biosynthesis or recycling of the cofactor tetrahydrobiopterin (BH4) by the
patient
The coenzyme (called biopterin) can be supplemented as treatment.
Those who suffer from PKU must be supplemented with tyrosine to account for phenylalanine
hydroxylase deficiency in converting phenylalanine to tyrosine sufficiently
Tetrahydrobiopterin is required to convert phenylalanine to tyrosine, but it is also required to
convert tyrosine to L-DOPA (via the enzyme tyrosine hydroxylase), which in turn is converted
to dopamine.
Low levels of dopamine lead to high levels of prolactin.
By contrast, in classical PKU, prolactin levels would be relatively normal.
Tetrahydrobiopterin deficiency can be caused by defects in four different genes.
These types are known as HPABH4A, HPABH4B, HPABH4C, and HPABH4D
Tetrahydrobiopterin-deficient hyperphenylalaninemia
11. The enzyme phenylalanine hydroxylase normally converts the amino
acid phenylalanine into the amino acid tyrosine
If this reaction does not take place, phenylalanine accumulates and
tyrosine is deficient.
Excessive phenylalanine can be metabolized into phenylketones
through the minor route, a transaminase pathway with glutamate.
Metabolites
include phenylacetate, phenylpyruvate and phenethylamine.
Elevated levels of phenylalanine in the blood and detection of
phenylketones in the urine is diagnostic
Phenylalanine is a large, neutral amino acid (LNAA).
LNAAs compete for transport across the blood–brain barrier (BBB) via
the large neutral amino acid transporter (LNAAT).
12. If PKU is diagnosed early enough, an affected newborn can grow up with normal brain
development, but only by managing and controlling Phe levels through diet, or a combination of
diet and medication.
Optimal health ranges (or "target ranges") are between 120 and 360 µmol/L.
When Phe cannot be metabolized by the body, abnormally high levels accumulate in the blood
and are toxic to the brain
PKU patients must adhere to a special diet low in Phe for optimal brain development.
"Diet for life" has become the standard recommended by most experts.
The diet requires severely restricting or eliminating foods high in Phe, such
as meat, chicken, fish, eggs, nuts, cheese, legumes, milk and other dairy products.
Starchy foods, such as potatoes, bread, pasta, and corn, must be monitored.
Infants may still be breastfed to provide all of the benefits of breastmilk, but the quantity must
also be monitored and supplementation for missing nutrients will be required.
The sweetener aspartame, present in many diet foods and soft drinks, must also be avoided, as
aspartame contains phenylalanine.
Treatment
13.
14. The oral administration of tetrahydrobiopterin (or BH4) (a cofactor
for the oxidation of phenylalanine) can reduce blood levels of this
amino acid in certain patients.[
The company BioMarin Pharmaceutical has produced a tablet
preparation of the compound sapropterin dihydrochloride (Kuvan),
which is a form of tetrahydrobiopterin.
Kuvan is the first drug that can help BH4-responsive PKU patients
(defined among clinicians as about 1/2 of the PKU population) lower
Phe levels to recommended ranges.
Working closely with a dietitian, some PKU patients who respond to
Kuvan may also be able to increase the amount of natural protein
they can eat.
After extensive clinical trials, Kuvan has been approved by the FDA
for use in PKU therapy.
Some researchers and clinicians working with PKU are finding Kuvan
a safe and effective addition to dietary treatment and beneficial to
patients with PKU
15. For women with phenylketonuria, it is essential for the health of their children to
maintain low Phe levels before and during pregnancy.
Though the developing fetus may only be a carrier of the PKU gene, the intrauterine
environment can have very high levels of phenylalanine, which can cross the placenta.
The child may develop congenital heart disease, growth retardation, microcephaly and
mental retardation as a result
In most countries, women with PKU who wish to have children are advised to lower
their blood Phe levels (typically to between 2 and 6 micromol/deciliter) before they
become pregnant, and carefully control their levels throughout the pregnancy.
In many cases, as the fetus' liver begins to develop and produce PAH normally, the
mother's blood Phe levels will drop, requiring an increased intake to remain within the
safe range of 2–6 micromol/dL
When low phenylalanine levels are maintained for the duration of pregnancy, there
are no elevated levels of risk of birth defects compared with a baby born to a non-PKU
Maternal phenylketonuria
16. Incidence
United States Caucasians are affected at a rate of 1 in 10,000
Turkey has the highest documented rate in the world, with 1 in 2,600 births
Finland and Japan have extremely low rates with fewer than one case of PKU in 100,000 births
Roma population with an extremely high incidence of PKU (one case in 40 births) due to
extensive inbreeding
Countr Incidence of PKU
China 1 in 18,000
Finland 1 in 100,000
Ireland 1 in 4,500
Japan 1 in 120,000
Korea 1 in 41,000
Norway 1 in 13,000
Turkey 1 in 2,600
India 1 in 18,300
U.S 1 in 15,000